Apixaban vs warfarin: rise of newer anticoagulant
Druggist
APRIL 29, 2021
Apixaban stops the production of enzymes (chemicals) required for the production of fibrin , a compound (protein) that plays a role in the clotting of the blood. Patients who have cancer or receive chemotherapy. As the name suggests, apixaban and other newer anticoagulants do not affect vitamin K production.
98 
Let's personalize your content